Xanthine oxidase (XO) is a crucial enzyme for UA production, and allopurinol (an XO inhibitor) has been shown to affect the progression of NAFLD (13, 14, 15). The gene discussed is XDH; the disease is metabolic dysfunction-associated steatotic liver disease.